Controllable Silver Release for Efficient Treatment of Drug‐Resistant Bacterial‐Infected Wounds

Abstract

AbstractThe use of traditional Ag‐based antibacterial agents is usually accompanied by uncontrollable silver release, which makes it difficult to find a balance between antibacterial performance and biosafety. Herein, we prepared a core‐shell system of ZIF‐8‐derived amorphous carbon‐coated Ag nanoparticles (Ag@C) as an ideal research model to reveal the synergistic effect and structure‐activity relationship of the structural transformation of carbon shell and Ag core on the regulation of silver release behavior. It is found that Ag@C prepared at 600 °C (AC6) exhibits the best ion release kinetics due to the combination of relatively simple shell structure and lower crystallinity of the Ag core, thereby exerting stronger antibacterial properties (>99.999 %) at trace doses (20 μg mL−1) compared with most other Ag‐based materials. Meanwhile, the carbon shell prevents the metal Ag from being directly exposed to the organism and thus endows AC6 with excellent biocompatibility. In animal experiments, AC6 can effectively promote wound healing by inactivating drug‐resistant bacteria while regulating the expression of TNF‐α and CD31. This work provides theoretical support for the scientific design and clinical application of controllable ion‐releasing antibacterial agents.